Beghi, Ettore http://orcid.org/0000-0003-2542-0469
Giussani, Giorgia
Westenberg, Erica
Allegri, Ricardo
Garcia-Azorin, David
Guekht, Alla
Frontera, Jennifer
Kivipelto, Miia
Mangialasche, Francesca
Mukaetova-Ladinska, Elizabeta B.
Prasad, Kameshwar
Chowdhary, Neerja
Winkler, Andrea Sylvia
Funding for this research was provided by:
World Health Organization
Article History
Received: 10 August 2021
Revised: 13 October 2021
Accepted: 13 October 2021
First Online: 21 October 2021
Declarations
:
: Dr. Beghi reports grants from the Italian Ministry of Health, grants from SOBI, personal fees from Arvelle Therapeutics, grants from American ALS Association, outside the submitted work. Dr. Allegri reports grants from Fleni Neurological Institute (Buenos Aires, Argentina), grants from CONICET (National Council of Scientific and Technological Research), Argentina, grants from Washington University, Subcontract NIH (USA), grants from Alzheimer Association (USA), outside the submitted work. Dr. Garcia-Azorin reports grants from International Headache Society, personal fees from the World Health Organization, personal fees from Lilly, personal fees from Teva, personal fees from Novartis, personal fees from Allergan, personal fees from Chiesi, grants from the Spanish Society of Neurology, grants from Fundacion Estudios de Ciencias de la Salud de Castilla y Leòn, grants from Colegio de Medicos de Valladolid, outside the submitted work. Dr. Frontera reports grants from NIH/NINDS and NIH/NIA for COVID-related research. Dr. Winkler and Dr. Westenberg report grants from School of Medicine of the Technical University of Munich, outside the submitted work. Dr. Guekht report a grant from the Russian Scientific Foundation, outside of the submitted work.All the other authors have nothing to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.